WAT 345.12 (-4.83%)
US9418481035Medical Diagnostics & ResearchDiagnostics & Research

Waters (WAT) Competitor Comparison

We are evaluating the key criteria listed to compare Waters (WAT) against its competitors in the Diagnostics & Research industry.

Performance 3 years - WAT ranking 10 / 58

These are the competitors of Waters in the industry Diagnostics & Research ranked by performance 3 years
1. Natera NTRA
257.26
2. Meridian Bioscience VIVO
246.63
3. RadNet RDNT
126.89
4. Medpace Holdings MEDP
96.58
5. Lantheus Holdings LNTH
94.73
6. Heska HSKA
41.31
7. PerkinElmer PKI
21.19
8. Quest Diagnostics DGX
16.13
9. Ortho Clinical Diagnostics Holdings OCDX
13.74
10. Waters WAT
10.71
11. Anixa Biosciences ANIX
5.32
12. Sera Prognostics SERA
-0.28
13. Laboratory Corp of America Holdings LH
-2.19
14. Twist Bioscience TWST
-11.3
15. Thermo Fisher Scientific TMO
-13.32
16. Agilent Technologies A
-14.36
17. Mettler-Toledo MTD
-15.85
18. Qiagen QGEN
-17.41
19. Syneos Health SYNH
-19.01
20. Danaher DHR
-19.39
21. IQVIA Holdings IQV
-21.3
22. Olink Holding OLK
-22.2
23. IDEXX Laboratories IDXX
-23.14
24. Icon ICLR
-24.43
25. Guardant Health GH
-27.32
26. Bioventus BVS
-31.17
27. Exact Sciences EXAS
-34.88
28. DexCom DXCM
-43.4
29. Charles River Laboratories CRL
-44.18
30. NeoGenomics NEO
-45.37
31. Sotera Health SHC
-45.86
32. CareDx CDNA
-52.86
33. Personalis PSNL
-53.83
34. Exagen XGN
-54.29
35. MaxCyte MXCT
-61.87
36. Myriad Genetics MYGN
-64.73
37. National Research NRC
-66.13
38. Global Cord Blood CO
-67.25
39. Psychemedics PMD
-67.91
40. Enzo Biochem ENZ
-70.36
41. Fulgent Genetics FLGT
-72.19
42. Neogen NEOG
-72.28
43. Biodesix BDSX
-72.97
44. Precipio PRPO
-75.12
45. Illumina ILMN
-76.01
46. MDxHealth MDXH
-81.27
47. Pacific Biosciences of California PACB
-87.74
48. bioAffinity Technologies BIAF
-88.45
49. Co-Diagnostics CODX
-88.94
50. Trinity Biotech TRIB
-89.06
51. Organovo Holdings ONVO
-89.19
52. Interpace Biosciences IDXG
-89.51
53. Inotiv NOTV
-90.58
54. Neuronetics STIM
-91.07
55. DarioHealth DRIO
-93.77
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-96.52
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.